The Ichthyoses pp 157-161 | Cite as

The Sjögren-Larsson Syndrome

  • Heiko Traupe

Abstract

In 1957, Sjögren and Larsson [18] reported on 28 patients belonging to 13 families who all lived in the North Swedish province of Västerbotten. These patients suffered from a syndrome characterized by pronounced congenital ichthyosis, severe mental retardation, and symmetric spastic pyramidal symptoms of the Little type. Sjögren and Larsson demonstrated consanguinity in eight of the 13 families. They concluded that the symptom complex they had observed represented a unique and new genetic disorder inherited as an autosomal recessive trait. Their findings were soon confirmed by many groups reporting cases from all over the world [3-5, 7, 15]. Two years after delineation of the syndrome by Sjögren and Larsson, Greither [4] pointed out that the association of ichthyosis, mental retardation, and spastic paresis of the Little type had already been described 30 years earlier in a very brief case report by Pardo-Castello and Faz [14] in 1932. Nevertheless, the condition rightfully bears the name of Sjögren and Larsson, since their tremendous work established the syndrome as a unique condition.

Keywords

Retina Peri Adenine Triglyceride Dition 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anton-Lamprecht I (1978) Ultrastructural criteria for the distinction of different types of inherited ichthyosis. In: Marks R, Dykes PJ (eds) The ichthyoses. MTP, Lancaster, pp 71–87CrossRefGoogle Scholar
  2. 2.
    Avigan J, Campbell BD, Yost DA, Hemell O, Holmgren G, Jagell SF (1985) Sjögren-Lars- son syndrome: delta5- and delta6-fatty acid desaturates in skin fibroblasts. Neurology 35:401–403PubMedCrossRefGoogle Scholar
  3. 3.
    Daicker B (1972) Zur Kenntnis von Substrat und Bedeutung der sogenannten Schneckenspuren der Retina. Ophthalmologica 165:360–365PubMedCrossRefGoogle Scholar
  4. 4.
    Greither A (1959) Über das Syndrom: Ichthyosis congenita, Schwachsinn und spastische Störungen vom Typ der Littleschen Krankheit. Hautarzt 10:403–408PubMedGoogle Scholar
  5. 5.
    Guilleminault C, Harpey JP, Lafourcade J (1973) Sjögren-Larsson syndrome. Report of two cases in twins. Neurology 23:367–373PubMedCrossRefGoogle Scholar
  6. 6.
    Harper JI (1987) Analysis of essential fatty acid metabolism in Sjögren-Larsson syndrome. In: Meneghini CL, Bonifazi E (eds) Proceedings 2nd Congress of the European Society for Pediatric Dermatology, Bari, Oct 2–4, 1987. Pediatr Dermatol News 6:7–9Google Scholar
  7. 7.
    Heijer A, Reed WB (1965) Sjögren-Larsson syndrome. Arch Dermatol 92:545–552PubMedCrossRefGoogle Scholar
  8. 8.
    Hernell O, Holmgren G, Jagell SF, Johnson SB, Holman RT (1982) Suspected faulty essential fatty acid metabolism in Sjögren-Larsson syndrome. Pediatr Res 16:45–49PubMedGoogle Scholar
  9. 9.
    Hooft C, Kriekemans J, van Acker K, Devos E, Traen S, Verdonck G (1967) Sjögren-Larsson syndrome with exudative enteropathy. Influence of medium-chain triglycerides on the symptomatology. Helv Paediatr Acta 5:447–458Google Scholar
  10. 10.
    Jagell S, Polland W, Sandgren O (1980) Specific changes in the fundus typical for the Sjögren-Larsson syndrome. An ophthalmological study. Acta Ophthalmol (Copenh) 58:321–330CrossRefGoogle Scholar
  11. 11.
    Jagell S, Gustavson KH, Holmgren G (1981) Sjögren-Larsson syndrome in Sweden. A clinical, genetic and epidemiological study. Clin Genet 19:233–256PubMedCrossRefGoogle Scholar
  12. 12.
    Kouseff BG, Matsuoka LY, Stenn KS, Jobbins JC, Mahoney MJ, Hashimoto K (1982) Prenatal diagnosis of Sjögren-Larsson syndrome. J Pediatr 101:998–1001CrossRefGoogle Scholar
  13. 13.
    Liden S, Jagell S (1984) The Sjögren-Larsson syndrome. Int J Dermatol 23:247–253PubMedCrossRefGoogle Scholar
  14. 14.
    Pardo-Castello V, Faz H (1932) Ichthyosis with Little’s disease. Arch Dermatol Syph (Chicago) 26:915Google Scholar
  15. 15.
    Reich H (1972) Sjögren-Larsson-Syndrom. Med Klin 67:909–912PubMedGoogle Scholar
  16. 16.
    Rizzo WB, Craft DA, Dammann AL, Philips MW (1987) Fatty alcohol metabolism in cultured human fibroblasts: evidence for a fatty alcohol cycle. J Biol Chem 262:17412–17419PubMedGoogle Scholar
  17. 17.
    Rizzo WB, Dammann AL, Craft DA (1988) Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol nicotinamide adenine dinucleotide oxidoreductase activity. J Clin Invest 81:738–744PubMedCrossRefGoogle Scholar
  18. 18.
    Sjögren T, Larsson T (1957) Oligophrenia in combination with congenital ichthyosis and spastic disorders. Acta Psychiatr Scand 32 [Suppl 113]:1–113CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • Heiko Traupe
    • 1
  1. 1.Department of Human GeneticsUniversity of NijmegenHB NijmegenThe Netherlands

Personalised recommendations